dihexa pnb-0408 c-met hgfr activator Targeting HGF/c-MET signaling to regulate the tumor microenvironment: Implications for counteracting tumor immune evasion dihexa pnb-0408 c-met hgfr activator
dihexa pnb 0408 c met hgfr activator Small molecule activation of the neurotrophin hepatocyte growth factor to treat Alzheimer disease Dihexa (PNB 0408) c Met HGFR Activator dihexa chemical properties solubility stability Cabozantinib hydrochloride c Met inhibitor CAS 1817759 42 4 Dihexa (PNB 0408) C27H44N4O5 CID 125355097 PubChem Activated HGF c Met Axis in Head and Neck Cancer Dihexa MedChem Express MET an ideal target for antibody drug conjugate therapy, plus nivolumab Cancer Biology
Pay in 4 interest-free payments of $7.36 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7




